15 results
10-K
2023 FY
EX-3.2
DNTH
Dianthus Therapeutics Inc
Annual report
21 Mar 24
4:07pm
8-K
EX-3.1
DNTH
Dianthus Therapeutics Inc
12 Sep 23
Magenta Therapeutics Announces Completion of Merger with Dianthus Therapeutics and Implementation of Reverse Stock Split
4:05pm
S-4
EX-3.1
DNTH
Dianthus Therapeutics Inc
15 May 23
Registration of securities issued in business combination transactions
8:39am
S-4
EX-3.2
DNTH
Dianthus Therapeutics Inc
15 May 23
Registration of securities issued in business combination transactions
8:39am
S-4
EX-3.3
DNTH
Dianthus Therapeutics Inc
15 May 23
Registration of securities issued in business combination transactions
8:39am
8-A12B
EX-3.1
nim4k b6ymzlr1ute
31 Mar 23
Registration of securities on exchange
4:16pm
8-K
EX-3.1
0a4euynt
13 Dec 22
Magenta Therapeutics Presents Positive MGTA-117 Clinical Data at the American Society of Hematology (ASH) Annual Meeting and Provides Program Updates
8:36am
8-K
EX-3.1
bfnb9ac
25 Jun 18
Amendments to Articles of Incorporation or Bylaws
4:49pm
8-K
EX-3.2
rs6zkpn9vqj79u
25 Jun 18
Amendments to Articles of Incorporation or Bylaws
4:49pm
S-1/A
EX-3.4
iymu9
8 Jun 18
IPO registration (amended)
7:03am
S-1/A
EX-3.2
dx2nna0gv is89u1
8 Jun 18
IPO registration (amended)
7:03am
S-1
EX-3.3
7yovg67wjl7znt7kl22
24 May 18
IPO registration
4:14pm
S-1
EX-3.1
ofbsjb50qiz1hrn
24 May 18
IPO registration
4:14pm
DRS/A
EX-3.1
zkxugrvcjwbwicoe0s
8 May 18
Draft registration statement (amended)
12:00am
DRS
EX-3
zmww56kh
28 Mar 18
Draft registration statement
12:00am
- Prev
- 1
- Next